Research suggests that alcohol drives cancer by at least five different mechanisms, with the risk of cancer increasing the more a person drinks. And the carcinogenic effects of alcohol may be more pronounced in people with a genetic predisposition to cancer.
Although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new report.
Cancer diagnoses are expected to exceed two million in 2025, with approximately 618,120 deaths predicted, according to the American Cancer Society’s annual cancer trends report.
The American Cancer Society's annual cancer trend report shows cancer mortality is decreasing but cancer rates are increasing in young adults and women.
Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — including colorectal, gastric, kidney and liver cancer — is also on the rise, though cancer among patients under 50 is still relatively rare overall, Dr. Partridge said.
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.
ESPN's Dick Vitale to call First game
A new Federal Trade Commission (FTC) report found that the three largest Pharmacy Benefit Managers (PBMs) have taken in large profits on lifesaving medicine for heart disease, cancer and HIV. Pharmacy Benefit Managers are third-party companies connected to pharmacies that are intermediaries between insurance providers and pharmaceutical manufacturers and claim to reduce consumer costs.
While deaths from cancer have decreased overall, the study shows cancer rates keep going up − especially among women. Researchers also found middle-aged women, like the Princess of Wales, age 43, now have a slightly higher cancer risk than their male counterparts and young women are almost twice as likely to be diagnosed as young men.
Trends in breast, prostate and lung cancer are shifting who is most at-risk.